SCHEMBL1160119

SCHEMBL1160119

CCCCCOP(O)OCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 3/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
THRB P10828 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.38
USP2 O75604 1/20 0.38
LPAR3 Q9UBY5 6/20 0.37
LPAR2 Q9HBW0 5/20 0.37
LPAR1 Q92633 2/20 0.37
NAAA Q02083 1/20 0.37
RECQL P46063 2/20 0.35
CES2 O00748 1/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17831338 0.98 HTT (0.41) CA12CA1CA2CA9HTT
SCHEMBL258456 0.95 CA12 (0.41) CA12CA1CA2CA9HTT
SCHEMBL258261 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL6267890 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL1260510 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL456550 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL8177542 0.92 TSHR (0.39) CA12CA1CA2CA9HTT
SCHEMBL14351508 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL15722834 0.92 THRB (0.44) CA12CA1CA2CA9HTT
SCHEMBL164198 0.92 THRB (0.44) CA12CA1CA2CA9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3553068-B1 YDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL IP AMERICA INC (US) 2021-04-28 EP disclosed
EP-3553068-A1 HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL-IP America Inc. (US) 2019-10-16 EP disclosed
EP-2909218-B1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL IP AMERICA INC (US) 2019-07-10 EP disclosed
CN-105503946-B The manufacturing method of hydroxymethyl phosphonic acid ester, polyurethane foam formation composition, polyurethane foam and the product being made from it ICL-IP美国公司 2018-10-12 CN disclosed
CN-107383093-A Hydroxymethyl phosphonic acid ester, composition, polyurethane foam and product ICL-IP美国有限公司 2017-11-24 CN disclosed
CN-104755487-B Method for preparing hydroxymethylphosphonate, polyurethane foam-forming composition prepared thereby, polyurethane foam and article ICL-IP美国有限公司 2017-09-19 CN disclosed
US-9657151-B1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. (US) 2017-05-23 US disclosed
US-20170137590-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL-IP America Inc (US) 2017-05-18 US disclosed
US-9593220-B2 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. (US) 2017-03-14 US disclosed
US-20160347921-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL-IP AMERICA INC. 2016-12-01 US disclosed
EP-2376507-B1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATES ICL IP AMERICA INC (US) 2013-05-15 EP disclosed
US-8198341-B2 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. (US) 2012-06-12 US disclosed
US-20110257287-A1 Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom STOWELL JEFFREY K 2011-10-20 US disclosed
EP-2376507-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM ICL-IP America Inc. (US) 2011-10-19 EP disclosed
US-8008384-B2 Liquid butylaryl phosphite compositions CHEMTURA CORPORATION (US) 2011-08-30 US disclosed
WO-2011014212-A1 LIQUID BUTYLARYL PHOSPHITE COMPOSITIONS CHEMTURA CORPORATION (US) 2011-02-03 WO disclosed
US-20100190900-A1 LIQUID BUTYLARYL PHOSPHITE COMPOSITIONS CHEMTURA CORPORATION (US) 2010-07-29 US disclosed
WO-2010080425-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM SUPRESTA LLC. (US) 2010-07-15 WO disclosed
US-20100160468-A1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. 2010-06-24 US disclosed
US-20100076131-A1 LIQUID BUTYLARYL PHOSPHITE COMPOSITIONS AND ALKYLATE COMPOSITIONS FOR MANUFACTURING SAME CHEMTURA CORPORATION (US) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257287-A1 Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom PFAS, PGM2, NEFM CA12 2013/4885CA1 1012/4885CA2 1625/4885
US-20160347921-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM PFAS, PFKFB2, PFKFB1 CA12 2361/4885CA1 1237/4885CA2 2128/4885
US-20100160468-A1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom PFAS, PGM2, NEFM CA12 2013/4885CA1 1012/4885CA2 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.